Faculty of Fundamental Medicine, Moscow State University named after M.V. Lomonosov together with Pharmacovigilance Agency “Pharmcompliance” LLC successfully organized the professional development program “Organization of a Pharmacovigilance System for Marketing Authorization Holders”.
Key updates of the Eurasian Economic Union (EAEU) Good Pharmacovigilance Practice (GVP) effective in December 2022, as well as the changes in the processes of marketing authorization holders were in the focus of the program. As part of the program, the specifics and differences of national PV requirements of the EAEU Member States were discussed.
39 participants successfully completed the program and got a state Certificate from Moscow State University.
Key speakers: representatives of the Federal Service for Surveillance in Healthcare (Roszdravnadzor), independent experts, as well as leading PV specialists of international and local pharmaceutical companies.